INNOVATE BIOPHARMACEUTICLS I
(45782F105)
Funds Reporting Holdings of INNOVATE BIOPHARMACEUTICLS I according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Sabby Management LLC | 1,336,248 | $1,550k | Jun 30, 2019 | Aug 14, 2019 | |
Hillview Capital Advisors LLC | 19,610 | $23k | Jun 30, 2019 | Aug 1, 2019 |